Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Elidel studies reveal patient satisfaction with eczema treatment

Sep. 8, 2003

New glucocorticoids for inflammatory and allergic disorders covered by GSK patent

Sep. 5, 2003

Phase I/II trials cleared for topical PTH (7-34) in chemotherapy-induced alopecia

Aug. 26, 2003

CX-659S prevents rebound after prednisolone treatment

Aug. 25, 2003

Genzyme submits regulatory submission for Hylaform

Aug. 21, 2003

New hair growth-promoting agents prepared and tested at Kao

Aug. 20, 2003

ICN expands Kinerase license with Senetek

Aug. 20, 2003

Arriva-ProMetic completes phase I trial of rAAT in atopic dermatitis patients

Aug. 19, 2003

Galderma presents new PPARgamma agonists with potential in dermatological disorders

Aug. 12, 2003

Pivotal phase III trial for Cellegesic makes solid progress

Aug. 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....